CRGX — CARGO Therapeutics Cashflow Statement
0.000.00%
HealthcareMid Cap
- $725.76m
- $349.84m
Annual cashflow statement for CARGO Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Net Income/Starting Line | -5.85 | -41 | -98.1 |
Depreciation | |||
Non-Cash Items | 0.637 | 8.51 | 13.3 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 0.254 | 2.97 | 2.21 |
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Accrued Expenses | |||
Cash from Operating Activities | -4.94 | -29.1 | -81.2 |
Capital Expenditures | -0.442 | -2.72 | -8.28 |
Purchase of Fixed Assets | |||
Other Investing Cash Flow Items | 0 | -0.558 | -0.715 |
Purchase of Investments | |||
Cash from Investing Activities | -0.442 | -3.28 | -8.99 |
Financing Cash Flow Items | 0 | 0.232 | -5.47 |
Other Financing Cash Flow | |||
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 5.41 | 34.2 | 495 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 0.03 | 1.83 | 404 |